The 2016 WHO Classification of Tumors of the Central Nervous System defined AT/RT by alterations of either INI1 protein (SMARCB1 gene), or rarely, BRG1 protein (SMARCA4 gene) (4). The gene discussed is SMARCA4; the disease is ataxia telangiectasia.